Year: 2026
Type: dissertation
Abstract: Programmed cell death (PCD) is a vital evolutionarily conserved process seen in all metazoans involved in phenomena including development, pathogen removal, oncogene suppression, and cellular homeostasis. Two major forms of PCD are: (1) apoptosis, a non-lytic pathway involving the activation of cysteine-aspartate proteases (caspases), cell shrinking, and the release of small membrane-bound apoptotic bodies; and (2) necroptosis, a programmed form of lytic necrosis involving phosphorylation of the serine/threonine kinases, RIPK1/3 that results in cytomegaly, cell swelling (oncosis), eventual loss of plasma membrane integrity, and bursting. In most differentiated cell types, apoptosis and necroptosis are traditionally understood to operate via “winner-take-all” execution, with necroptosis acting as a backup form of PCD in many cell types. Our laboratory has recently identified a novel form of apoptotic-necroptotic “cooperative” PCD unique to stem cells, observed from treatment with the chemotherapeutic, cisplatin, wherein the inhibition/knockout of necroptotic RIPK3 both protects cells against cisplatin-induced PCD and reduces the rate of apoptotic caspase-3 cleavage; however, the exact downstream signalling events and regulatory mechanisms are currently unknown. I hypothesized that these cooperative interactions occurred due to the external influence of the inhibitors of apoptosis (IAPs). In this thesis, I have thoroughly investigated downstream apoptotic and necroptotic signalling and potential regulatory proteins in cooperative in PCD in stem cells and demonstrated the key findings that: (1) cisplatin does not induce caspase-8 and bid cleavage; (2) the loss of caspase-9 protects against cisplatin-mediated PCD; (3) the loss of MLKL does not affect the rate of caspase-3 cleavage yet mildly enhances PCD; (4) the loss of RIPK3 reduces the rates of caspase-7 and caspase-9 cleavage but does not affect the rate of mitochondrial cytochrome c release, or AKT phosphorylation; (5) pyroptosis-associated gasdermin E (GSDME) is not involved in cooperative PCD; and (6) the apoptotic-necroptotic interactions in cooperative PCD do not occur due to the influence of cIAP1/2, XIAP, or survivin. Future investigations into cooperative PCD, including examining potential involvement of PANoptosome initiator proteins, NLRP12, AIM2, or ZBP1 or the inflammasome sensor, CARD8, may be of keen interest for ES cell-related areas of study including cancer stem cell-based tumorigenesis.
Source: TSpace (University of Toronto)
Author: Rodgers, Christopher Edward
Institution: University of Toronto
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7204021229
